Literature DB >> 16219719

Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome.

Esra Tasali1, Eve Van Cauter, David A Ehrmann.   

Abstract

CONTEXT: Women with polycystic ovary syndrome (PCOS) are insulin resistant and are at increased risk for sleep apnea, which, in turn, may contribute to insulin resistance.
OBJECTIVE: The objective of this study was to determine relationships between risk and severity of obstructive sleep apnea (OSA) and glucose metabolism in PCOS. DESIGN AND
SETTING: This study included two cohorts of women with PCOS in a tertiary care hospital. PATIENTS AND MAIN OUTCOME MEASURES: Cohort 1 included 40 nondiabetics who completed the Epworth Sleepiness Scale, the Pittsburgh Sleep Quality, and the Berlin Questionnaire to assess risk of OSA; 32 of the 40 women had an oral glucose tolerance test. Cohort 2 included eight women who had a sleep study, glycosylated hemoglobin level, and an oral glucose tolerance test.
RESULTS: In cohort 1, 62.5% of the women had poor sleep quality by Pittsburgh Sleep Quality Index, and 18 (45%) had chronic daytime sleepiness by Epworth Sleepiness Scale. Thirty of the 40 women had a high risk of OSA by Berlin Questionnaire. Women with high OSA risk had higher fasting insulin levels and homeostasis model assessment index compared with those with low OSA risk (168.2 +/- 17.3 vs. 97.2 +/- 6.4 pmol/liter, P = 0.011; 6.3 +/- 0.7 vs. 3.6 +/- 0.3 mg/dl x microU/ml, P = 0.014, respectively). Among women with normal glucose tolerance, insulin levels were significantly higher in those at high vs. low OSA risk, independently of body mass index. Women in cohort 2 had rapid eye movement (REM)-predominant OSA with lower sleep efficiency, longer sleep latency, and less REM sleep than controls. Glycosylated hemoglobin levels and the area under the glucose curve positively correlated with the apnea-hypopnea index (rP = 0.82, P = 0.013; rP = 0.96, P = 0.0008, respectively) and the number of oxygen desaturations in REM sleep (rP = 0.97, P = 0.0009; rP = 0.97, P = 0.005, respectively).
CONCLUSION: PCOS is associated with poor sleep quality, daytime sleepiness, and increased risk for OSA. Insulin levels and measures of glucose tolerance in PCOS are strongly correlated with the risk and severity of OSA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16219719     DOI: 10.1210/jc.2005-1084

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  30 in total

1.  The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome.

Authors:  Richard S Legro; Allen R Kunselman; Robert G Brzyski; Peter R Casson; Michael P Diamond; William D Schlaff; Gregory M Christman; Christos Coutifaris; Hugh S Taylor; Esther Eisenberg; Nanette Santoro; Heping Zhang
Journal:  Contemp Clin Trials       Date:  2012-01-13       Impact factor: 2.226

2.  Sleep Apnea and its association with the Stress System, Inflammation, Insulin Resistance and Visceral Obesity.

Authors:  G Trakada; G Chrousos; S Pejovic; A Vgontzas
Journal:  Sleep Med Clin       Date:  2007-06

3.  The impact of insulin resistance and hyperandrogenemia on polysomnographic variables in obese adolescents with polycystic ovarian syndrome.

Authors:  Gideon de Sousa; Bernhard Schlüter; Dirk Buschatz; Thomas Menke; Eckardt Trowitzsch; Werner Andler; Thomas Reinehr
Journal:  Sleep Breath       Date:  2011-01-08       Impact factor: 2.816

Review 4.  Adverse Pregnancy Conditions, Infertility, and Future Cardiovascular Risk: Implications for Mother and Child.

Authors:  Ki Park; Janet Wei; Margo Minissian; C Noel Bairey Merz; Carl J Pepine
Journal:  Cardiovasc Drugs Ther       Date:  2015-08       Impact factor: 3.727

5.  Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women.

Authors:  Babak Mokhlesi; Bert Scoccia; Theodore Mazzone; Susan Sam
Journal:  Fertil Steril       Date:  2012-01-20       Impact factor: 7.329

Review 6.  Obstructive sleep apnea and the metabolic syndrome: The road to clinically-meaningful phenotyping, improved prognosis, and personalized treatment.

Authors:  Jordan Gaines; Alexandros N Vgontzas; Julio Fernandez-Mendoza; Edward O Bixler
Journal:  Sleep Med Rev       Date:  2018-09-03       Impact factor: 11.609

Review 7.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

Review 8.  Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies.

Authors:  Marla E Lujan; Donna R Chizen; Roger A Pierson
Journal:  J Obstet Gynaecol Can       Date:  2008-08

9.  Epidemiology of Obstructive Sleep Apnea: a Population-based Perspective.

Authors:  Won Lee; Swamy Nagubadi; Meir H Kryger; Babak Mokhlesi
Journal:  Expert Rev Respir Med       Date:  2008-06-01       Impact factor: 3.772

10.  Assessment of ultrasonographic features of polycystic ovaries is associated with modest levels of inter-observer agreement.

Authors:  Marla E Lujan; Donna R Chizen; Andrew K Peppin; Anita Dhir; Roger A Pierson
Journal:  J Ovarian Res       Date:  2009-06-10       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.